Does chemokine C-C motif ligand 18 expression correlate with tumor malignancy in breast cancer?
CCL18 is involved in the development of breast cancer. CCL18 is a better biomarker than MVD in determining whether the tumor is malignant and the severity of malignancy of breast cancer.
PTX3 may be a useful marker for differentiation of patients with severe disease in patients presenting with fever to the emergency department.